TeenScreen – Angel of Mercy or Pill-Pusher for Drug Industry Thu, 14 Apr 2005 An investigative reporter has dug up the facts behind TeenScreen, the aggressive marketing scheme that targets America’s school children who are being “screened” for undetected mental problems – even though no accurate diagnostic screening tool for…
20% volunteers drop out after suicide in Eli Lilly’s duloxetine trial Thu, 12 Feb 2004 The Associated Press reports that nearly a fifth of the volunteers testing Eli Lilly’s antidepressant drug, duloxetine, dropped out after Traci Johnson, a 19-year old student committed suicide at a company laboratory. “Three participants in…
Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…
AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.
A Come Back for Psychosurgery? Wed, 6 Aug 2003 The Los Angeles Times reports that experimental psychosurgery is once again on the rise – at Harvard’s Massachusetts General Hospital and Brown University. It is acknowledged that “Researchers still do not fully understand how the operations affect the brain, or why”……
Infomail Archive 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 19, 2003: Eli Lilly Prozac UK Fact Sheet: “Not Recommended” for Children – PMDD Withdrawn in UK Dec 19, 2003: Not-So-Public-Relations: Drug Industry & Bioethics – is it casuistry or sophistry? Dec 18, 2003:…
AHRP Letter to the editor re: editorial ARDS trial July 10, 2003. The New England Journal of Medicine. Volume 349:188-192 Number 2 http://content.nejm.org/cgi/content/extract/349/2/188 Note: The April 3, 2003 the NEJM contained an editorial in support of a controversial multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute…
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P New York, NY 10023 April 4, 2003 Tommy Thompson, Secretary Department of Health and Human Services Dockets Management Branch (HFA–305), Docket Number 02N–0475, Food and Drug Administration, 5630 Fishers Lane, Room 1061 Rockville, MD 20852. Re: Docket…
February 25, 2003 8:33 AM Trauma counseling retraumatizes_Repress Yourself_NYT “Repress Yourself” an article in Sunday’s New York Times magazine provides Congress with very good reasons for taking back public funds from the mental health trauma industry that it infused with cash after 9/11. A scientific study conducted in Israel found…
Internal Documents: Bayer Knew of Baycol Dangers _NYT Sun, 23 Feb 2003 The New York Times reports that internal company documents show that Bayer Pharmaceuticals continued to sell the lethal anti-cholesterol drug, Baycol, despite knowledge that it caused rhabdomyolysis, which causes muscle cells to break down and their contents to…
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION Testimony by Vera Hassner Sharav Committee on the Use of Third Party Toxicity Research with Human Research Participants Science, Technology, and Law Program The National Academies of Science January 8, 2003 My name is Vera Sharav and I am the president and founder of…
Testimony by Vera Hassner Sharav before the Committee on the Use of Third Party Toxicity Research with Human Research Participants; Science, Technology, and Law Program; The National Academies of Science Committee on the Use of Third Party Toxicity Research with Human Research Participants
My name is Vera Sharav and I am the president and founder of The Alliance for Human Research Protection (AHRP) a citizens’ watchdog organization monitoring human research to ensure that the moral principles enshrined in the Nuremberg Code and the Declaration of Helsinki are preserved and followed in experiments involving human beings.
